
2.51 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 0.53 Today|||52-Week Range 3.85 | -32.30% Year-to-Date |
The 6 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 4.05, with a high estimate of 5.42 and a low estimate of 1.02. The median estimate represents a +61.81% increase from the last price of 2.51.
The current consensus among 8 polled investment analysts is to Hold stock in ProQR Therapeutics NV. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.